Whitehawk Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WHWK and other ETFs, options, and stocks.

About WHWK

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. 

CEO
David Lennon
CEODavid Lennon
Employees
40
Employees40
Headquarters
Morristown, New Jersey
HeadquartersMorristown, New Jersey
Founded
2007
Founded2007
Employees
40
Employees40

WHWK Key Statistics

Market cap
146.75M
Market cap146.75M
Price-Earnings ratio
20.25
Price-Earnings ratio20.25
Dividend yield
Dividend yield
Average volume
134.00K
Average volume134.00K
High today
$2.93
High today$2.93
Low today
$2.66
Low today$2.66
Open price
$2.74
Open price$2.74
Volume
332.99K
Volume332.99K
52 Week high
$3.77
52 Week high$3.77
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

The current Whitehawk Therapeutics(WHWK) stock price is $2.90, with a market capitalization of 146.75M. The stock trades at a price-to-earnings (P/E) ratio of 20.25.

On 2026-01-14, Whitehawk Therapeutics(WHWK) stock traded between a low of $2.66 and a high of $2.93. Shares are currently priced at $2.90, which is +9.0% above the low and -1.0% below the high.

Whitehawk Therapeutics(WHWK) shares are trading with a volume of 332.99K, against a daily average of 134K.

During the past year, Whitehawk Therapeutics(WHWK) stock moved between $1.39 at its lowest and $3.77 at its peak.

During the past year, Whitehawk Therapeutics(WHWK) stock moved between $1.39 at its lowest and $3.77 at its peak.

People also own

Based on the portfolios of people who own WHWK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .